{"id":2594,"date":"2018-06-21T09:18:57","date_gmt":"2018-06-21T08:18:57","guid":{"rendered":"https:\/\/www.cilcare.com\/?p=2594"},"modified":"2018-06-21T09:18:57","modified_gmt":"2018-06-21T08:18:57","slug":"cilcare-amylgen-partner","status":"publish","type":"post","link":"https:\/\/www.cilcare.com\/jp\/2018\/06\/21\/cilcare-amylgen-partner\/","title":{"rendered":"CILcare and Amylgen partner against Alzheimer&#8217;s disease"},"content":{"rendered":"<h2 style=\"text-align: center;\">Age-related disorders, CILcare and Amylgen partner to propose unique preclinical models to assess the effects of health solutions on hearing and cognitive functions !<\/h2>\n<p style=\"text-align: left;\">It is established that <strong>hearing loss<\/strong> is one of the three major risk factors for dementia and is clearly linked to <strong>Alzheimer&#8217;s disease<\/strong>, which affects nearly<strong> 25 million<\/strong> people around the world, while <strong>466 million<\/strong> people have hearing loss. <strong>CILcare<\/strong>, the world- leading CRO specializing in hearing disorders and <strong>Amylgen<\/strong>, CRO specializing in neurodegenerative disorders, have decided to combine their expertise to propose unique preclinical tests, which assess both hearing loss and cognitive decline.<\/p>\n<blockquote><p><strong>\u201cThe exploration of the relationship between hearing loss and the onset of Alzheimer&#8217;s disease in preclinical phases will likely be key in targeting the right patient population in clinical trials, by means of patient selection based on their hearing status.&#8221;<\/strong> says Celia Belline, CEO CILcare<\/p><\/blockquote>\n<div style=\"width: 1200px;\" class=\"wp-video\"><video class=\"wp-video-shortcode\" id=\"video-2594-1\" width=\"1200\" height=\"675\" autoplay preload=\"metadata\" controls=\"controls\"><source type=\"video\/mp4\" src=\"http:\/\/cilcare.com\/wp-content\/uploads\/2018\/06\/amylgen_-_sam_-_v03_1280x720.mp4?_=1\" \/><a href=\"http:\/\/cilcare.com\/wp-content\/uploads\/2018\/06\/amylgen_-_sam_-_v03_1280x720.mp4\">http:\/\/cilcare.com\/wp-content\/uploads\/2018\/06\/amylgen_-_sam_-_v03_1280x720.mp4<\/a><\/video><\/div>\n<p>&nbsp;<\/p>\n<h3><a href=\"https:\/\/www.cilcare.com\/jp\/\" target=\"_blank\" rel=\"noopener\">About CILcare<\/a><\/h3>\n<p>CILcare is the world-leading services company for drug development in hearing and otic disorders. Based in Cambridge, Paris and Montpellier,\u00a0CILcare supports biotechs, medtechs and pharmas from all over the world in their preclinical and clinical development in hearing loss and tinnitus. CILcare has developed unique know-how to assess the safety and the efficacy of drug candidates and medical devices in drug-induced hearing loss, noise induced hearing loss, age-related hearing loss, salicylate-induced tinnitus, noise-induced tinnitus and otitis.\u00a0<a href=\"https:\/\/www.cilcare.com\/jp\/preclinical-services\/\" target=\"_blank\" rel=\"noopener\">Learn more about CILcare\u2019s expert biomedical research services<\/a>\u00a0or\u00a0<a href=\"https:\/\/www.cilcare.com\/jp\/contact-us\/\" target=\"_blank\" rel=\"noopener\">contact us<\/a>.<\/p>\n<h3><a href=\"http:\/\/www.amylgen.fr\/\">About Amylgen<\/a><\/h3>\n<div class=\"wpb_text_column wpb_content_element vc_custom_1484856381628 title2blc\">\n<div class=\"wpb_wrapper\">\n<p>Amylgen is a preclinical CRO offering a unique combination of validated\u00a0<em>in vivo<\/em>\u00a0models\u00a0and a full range\u00a0testing.\u00a0Fast and predictive screening of the effects of\u00a0drugs\u00a0and\u00a0nutraceuticals\u00a0on brain health. Based in Montpellier, Amylgen is at your service to provide quick POC for your product as a food supplement for brain health. <a href=\"http:\/\/www.amylgen.fr\/contact\/\">Contact Amylgen for more information<\/a>.<\/p>\n<\/div>\n<\/div>\n<div class=\"ubtn-ctn-center homebtn1\"><\/div>\n<p class=\"responsive-video-wrap clr\"><iframe src=\"https:\/\/player.vimeo.com\/video\/274454943?h=4c733be038&amp;dnt=1&amp;app_id=122963\" width=\"1200\" height=\"675\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\"><\/iframe><\/p>\n<p class=\"responsive-video-wrap clr\"><iframe src=\"https:\/\/player.vimeo.com\/video\/274454943?h=4c733be038&amp;dnt=1&amp;app_id=122963\" width=\"1200\" height=\"675\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\"><\/iframe><\/p>","protected":false},"excerpt":{"rendered":"<p>Age-related disorders, CILcare and Amylgen partner to propose unique preclinical models to assess the effects of health solutions on hearing and cognitive functions ! It is established that hearing loss is one of the three major risk factors for dementia and is clearly linked to Alzheimer&#8217;s disease, which affects nearly 25 million people around the world, while 466 million people have hearing loss. CILcare, the world- leading CRO specializing in hearing disorders and Amylgen, CRO specializing in neurodegenerative disorders, have decided to combine their expertise to propose unique preclinical tests, which assess both hearing loss and cognitive decline. \u201cThe exploration of the relationship between hearing loss and the onset of [&hellip;]<\/p>","protected":false},"author":3,"featured_media":2606,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"class_list":["post-2594","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events","entry","has-media"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CILcare and Amylgen partner against Alzheimer&#039;s disease - Cilcare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cilcare.com\/jp\/2018\/06\/21\/cilcare-amylgen-partner\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CILcare and Amylgen partner against Alzheimer&#039;s disease - Cilcare\" \/>\n<meta property=\"og:description\" content=\"Age-related disorders, CILcare and Amylgen partner to propose unique preclinical models to assess the effects of health solutions on hearing and cognitive functions ! It is established that hearing loss is one of the three major risk factors for dementia and is clearly linked to Alzheimer&#8217;s disease, which affects nearly 25 million people around the world, while 466 million people have hearing loss. CILcare, the world- leading CRO specializing in hearing disorders and Amylgen, CRO specializing in neurodegenerative disorders, have decided to combine their expertise to propose unique preclinical tests, which assess both hearing loss and cognitive decline. \u201cThe exploration of the relationship between hearing loss and the onset of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cilcare.com\/jp\/2018\/06\/21\/cilcare-amylgen-partner\/\" \/>\n<meta property=\"og:site_name\" content=\"Cilcare\" \/>\n<meta property=\"article:published_time\" content=\"2018-06-21T08:18:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2018\/06\/AMYLGEN-CILCARE_2017-05-22.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"684\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"CILcare\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"CILcare\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/\",\"url\":\"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/\",\"name\":\"CILcare and Amylgen partner against Alzheimer's disease - Cilcare\",\"isPartOf\":{\"@id\":\"https:\/\/www.cilcare.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2018\/06\/AMYLGEN-CILCARE_2017-05-22.png\",\"datePublished\":\"2018-06-21T08:18:57+00:00\",\"author\":{\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/#primaryimage\",\"url\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2018\/06\/AMYLGEN-CILCARE_2017-05-22.png\",\"contentUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2018\/06\/AMYLGEN-CILCARE_2017-05-22.png\",\"width\":1024,\"height\":684,\"caption\":\"amylgen_cilcare\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cilcare.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CILcare and Amylgen partner against Alzheimer&#8217;s disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cilcare.com\/#website\",\"url\":\"https:\/\/www.cilcare.com\/\",\"name\":\"Cilcare\",\"description\":\"Making hearing a priority\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cilcare.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac\",\"name\":\"CILcare\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g\",\"caption\":\"CILcare\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CILcare and Amylgen partner against Alzheimer's disease - Cilcare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cilcare.com\/jp\/2018\/06\/21\/cilcare-amylgen-partner\/","og_locale":"ja_JP","og_type":"article","og_title":"CILcare and Amylgen partner against Alzheimer's disease - Cilcare","og_description":"Age-related disorders, CILcare and Amylgen partner to propose unique preclinical models to assess the effects of health solutions on hearing and cognitive functions ! It is established that hearing loss is one of the three major risk factors for dementia and is clearly linked to Alzheimer&#8217;s disease, which affects nearly 25 million people around the world, while 466 million people have hearing loss. CILcare, the world- leading CRO specializing in hearing disorders and Amylgen, CRO specializing in neurodegenerative disorders, have decided to combine their expertise to propose unique preclinical tests, which assess both hearing loss and cognitive decline. \u201cThe exploration of the relationship between hearing loss and the onset of [&hellip;]","og_url":"https:\/\/www.cilcare.com\/jp\/2018\/06\/21\/cilcare-amylgen-partner\/","og_site_name":"Cilcare","article_published_time":"2018-06-21T08:18:57+00:00","og_image":[{"width":1024,"height":684,"url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2018\/06\/AMYLGEN-CILCARE_2017-05-22.png","type":"image\/png"}],"author":"CILcare","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"CILcare","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/","url":"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/","name":"CILcare and Amylgen partner against Alzheimer's disease - Cilcare","isPartOf":{"@id":"https:\/\/www.cilcare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/#primaryimage"},"image":{"@id":"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2018\/06\/AMYLGEN-CILCARE_2017-05-22.png","datePublished":"2018-06-21T08:18:57+00:00","author":{"@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac"},"breadcrumb":{"@id":"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/#primaryimage","url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2018\/06\/AMYLGEN-CILCARE_2017-05-22.png","contentUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2018\/06\/AMYLGEN-CILCARE_2017-05-22.png","width":1024,"height":684,"caption":"amylgen_cilcare"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cilcare.com\/2018\/06\/21\/cilcare-amylgen-partner\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cilcare.com\/"},{"@type":"ListItem","position":2,"name":"CILcare and Amylgen partner against Alzheimer&#8217;s disease"}]},{"@type":"WebSite","@id":"https:\/\/www.cilcare.com\/#website","url":"https:\/\/www.cilcare.com\/","name":"Cilcare","description":"Making hearing a priority","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cilcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac","name":"CILcare","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g","caption":"CILcare"}}]}},"_links":{"self":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/2594","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/comments?post=2594"}],"version-history":[{"count":0,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/2594\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media\/2606"}],"wp:attachment":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media?parent=2594"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/categories?post=2594"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/tags?post=2594"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}